The company in July appointed Jim Esinhart (image right) – the former CEO of Chiltern – as a non-executive director.
Esinhart began his career in industry at GlaxoSmithKline and then PharmaResearch Corporation. After working at Inveresk and Charles River Laboratories, he joined Chiltern in 2006 and became CEO in 2012.
Esinhart said: “I am delighted to have this opportunity to work with Ergomed’s management team and Board … With the benefit of my experience, there are considerable opportunities ahead for Ergomed to continue building to address the growing needs in our industry, and the unmet needs of patients worldwide.”
Ergomed also named Rolf Soderstrom as a non-executive director of the company, chairing Ergomed’s audit and risk committee, replacing Peter George who will remain a member of the remuneration committee and nomination committee.
Soderstrom joins the board of Ergomed with more than 30 years of experience in finance. He also was CFO of BTG plc from 2008 to 2018.